Progyny, Inc. EV/EBITDA

EV/EBITDA of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.


Highlights and Quick Summary

Current EV/EBITDA of Progyny, Inc. is 330.94 (as of December 30, 2020)
  • EV/EBITDA for the quarter ending September 29, 2021 was 139.75 (a -13.62% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by -57.77%
  • Annual EV/EBITDA for 2020 was 330.94 (a 691.89% increase from previous year)
  • Annual EV/EBITDA for 2019 was 41.79 (a 260.17% increase from previous year)
  • Annual EV/EBITDA for 2018 was 11.6 (a 0.0% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Progyny, Inc.

Most recent EV/EBITDAof PGNY including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Progyny, Inc.

Progyny, Inc. EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 139.75 161.78 198.95
2020 330.94 224.86 245.13 140.39 330.94
2019 41.79 11.6 11.6 11.6 41.79
2018 11.6 11.6
2017 11.6

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.